Latest Equities News

Page 170 of 399
Argent BioPharma has secured a transformative acquisition of AusCann’s core assets, bolstering its drug delivery technology and manufacturing capabilities ahead of a planned U.S. listing. The company also reported key clinical milestones and refinancing moves in its September 2025 quarterly update.
Ada Torres
Ada Torres
31 Oct 2025
NT Minerals Limited reported a net cash outflow of A$590,000 for Q3 2025 but bolstered its liquidity with A$1.07 million from investing activities, leaving it with over two quarters of funding runway.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Resources & Energy Group Limited (REZ) has secured approval to expand gold vat leach production at its East Menzies Gold Project, transitioning from trial to commercial scale. The company also announced a maiden JORC 2012 Inferred Mineral Resource at Gigante Grande, underpinning future growth.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Tryptamine Therapeutics has initiated the world’s first clinical trial of its IV-infused psilocin drug, TRP-8803, targeting Binge Eating Disorder, alongside a pioneering EEG biomarker collaboration and new funding.
Ada Torres
Ada Torres
31 Oct 2025
Challenger Gold Limited advances its Hualilan Gold Project with commissioning of the Casposo Toll Milling plant and key operational contracts, while Ecuador projects gain value following Lumina Gold’s takeover. A $30 million placement strengthens funding for upcoming milestones.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Nexion Group has completed the sale of its networks business for $4.1 million, marking a strategic pivot towards data centre operations and its AI-driven FuseAI software platform. The company is restructuring and preparing to resume ASX trading amid evolving revenue streams.
Sophie Babbage
Sophie Babbage
31 Oct 2025
Austin Metals Limited has agreed to sell its Broken Hill assets, focusing on its Western Australian gold projects, while reporting encouraging drilling results at Mt Sandy and Ashburton.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Recce Pharmaceuticals has commenced patient dosing in its pivotal Phase 3 trial for diabetic foot infections in Indonesia, supported by promising antibacterial efficacy data and extended funding arrangements.
Ada Torres
Ada Torres
31 Oct 2025
North Stawell Minerals has successfully closed its equity raising initiative, securing a total of $2.42 million to fuel exploration and project development across its key gold assets.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Complii FinTech Solutions reported a 4.9% year-on-year increase in annual recurring revenue, progressed a major CRM system upgrade, and secured a $1.217 million R&D rebate in Q1 FY26, while managing cash flow pressures.
Sophie Babbage
Sophie Babbage
31 Oct 2025
DGR Global Limited’s Q3 2025 report reveals ongoing project development, strategic equity holdings, and complex legal proceedings shaping its resource company creation model.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Atlantic Lithium has finalized revised fiscal terms with the Ghanaian government for its Ewoyaa Lithium Project and awaits parliamentary ratification, while reporting strong exploration results in Côte d’Ivoire and securing significant funding agreements.
Maxwell Dee
Maxwell Dee
31 Oct 2025